Browsing by 저자 : 김성배
전체 결과 47건 중 1-47 번을 표시중입니다.
- 1 Article A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis ? Zvirbule ; 김성배 ; A Brufsky ; et al 2021
- 2 Article A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy 고수진 ; 김성배 ; 김정은 ; et al 2020
- 3 Article A propensity score-matched comparison of recurrence outcomes after immediate implant vs autologous flap reconstruction in patients receiving neoadjuvant chemotherapy for breast cancer 고범석 ; 공경엽 ; 김성배 ; et al 2021
- 4 Article Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial 김성배 ; Andrew M Wardley ; Arlene Chan ; et al 2020
- 5 Article Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma 강지훈 ; 김도훈 ; 김성배 ; et al 2021
- 6 Article Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients Jong?HanYu ; 고범석 ; 공경엽 ; et al 2020
- 7 Article Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen 고범석 ; 공경엽 ; 김성배 ; et al 2020
- 8 Article Characteristics of metastatic brachial plexopathy in patients with breast cancer 김자영 ; 전재용 ; 최영준 ; et al 2020
- 9 Article Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer 고범석 ; 공경엽 ; 김선옥 ; et al 2021
- 10 Article Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study 조윤영 ; 유제상 ; 송계진 ; et al 2021
- 11 Article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial 김성배 ; Antonino Musolino ; Bella Kaufman ; et al 2021
- 12 Article Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial 김성배 ; Adam M Brufsky ; Barbara Haley ; et al 2021
- 13 Article Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study 김성배 ; Alice L Yu ; Chiun-Sheng Huang ; et al 2020
- 14 Article Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12. 김성배 ; Bhumsuk Keam ; Ho Jung An ; et al 2020
-
15
Dissertation
Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma : A retrospective analysis of 107 patients in a single center
김어진
2018
- 16 Article Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center 김성배 ; 김어진 ; 김용희 ; et al 2020
- 17 Article Is asymptomatic surveillance beneficial after standard treatment? A 10-year survival analysis of recurrent BC patients by detection method of recurrence 이새별 ; 안세현 ; 공경엽 ; et al 2020
- 18 Article Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study 고수진 ; 김건민 ; 김성배 ; et al 2021
- 19 Article Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study 고수진 ; 김건민 ; 김성배 ; et al 2021
- 20 Article Locoregional recurrence following nipple-sparing mastectomy with immediate breast reconstruction: Patterns and prognostic significance 고범석 ; 공경엽 ; 김성배 ; et al 2021
- 21 Article Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy 고범석 ; 공경엽 ; 김성배 ; et al 2020
- 22 Article Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens 김성배 ; Adam Brufsky ; Ava Kwong ; et al 2021
- 23 Article Oncologic Outcomes of Nipple-sparing Mastectomy and Immediate Reconstruction After Neoadjuvant Chemotherapy for Breast Cancer 고범석 ; 공경엽 ; 김성배 ; et al 2021
- 24 Article Oncologic Safety of Nipple-Sparing Mastectomy in Patients with Breast Cancer and Tumor-to-Nipple Distance <= 1 cm: A Matched Cohort Study 고범석 ; 공경엽 ; 김성배 ; et al 2021
- 25 Article Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting 김성배 ; Cynthia Villarreal-Garza ; Florencia Perazzo ; et al 2020
- 26 Article Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial 김성배 ; Andreas Makris ; Carsten Denkert ; et al 2021
- 27 Article Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer 김성배 ; 김지현 ; 김현선 ; et al 2021
- 28 Article Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer 김성배 ; 김지현 ; 김현선 ; et al 2021
- 29 Article Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study 김성배 ; Adam Knott ; Andreas Schneeweiss ; et al 2020
- 30 Article Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy 고범석 ; 공경엽 ; 곽성찬 ; et al 2021
- 31 Article Predictive Role of TP53, PIK3CA and MLL2 in ER+HER2+Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859] 공경엽 ; 김덕훈 ; 김성배 ; et al 2020
- 32 Article Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma 장정윤 ; 유제상 ; 송계진 ; et al 2020
- 33 Article Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer 구자윤 ; 김상윤 ; 김성배 ; et al 2020
- 34 Article Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer 고민지 ; 정진홍 ; 김수산 ; et al 2021
- 35 Article Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer 김성배 ; Antoine Adenis ; Chih-Hung Hsu ; et al 2020
- 36 Article Recurrence Outcomes After Nipple-Sparing Mastectomy and Immediate Breast Reconstruction in Patients with Pure Ductal Carcinoma In Situ 고범석 ; 공경엽 ; 김성배 ; et al 2020
- 37 Article Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES 김성배 ; Aditya Adhav ; Bulent Karabulut ; et al 2021
- 38 Article Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial. 김성배 ; Annabel Goodwin ; Joohyuk Sohn ; et al 2021
- 39 Article The Association between Herpes Zoster and Increased Cancer Risk: A Nationwide Population-Based Matched Control Study 심지훈 ; 조현석 ; 김영도 ; et al 2021
- 40 Article The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer 고범석 ; 김성배 ; 김수산 ; et al 2021
- 41 Article Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations 김성배 ; Alan L Ho ; Antonio Gualberto ; et al 2021
- 42 Article Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial 김성배 ; Aruna Mani ; Chiara Lambertini ; et al 2020
- 43 Article Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01) 김성배 ; Bhumsuk Keam ; Hee Kyung Ahn ; et al 2020
- 44 Article Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab 고범석 ; 공경엽 ; 김성배 ; et al 2021
- 45 Article Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma 강지훈 ; 김도훈 ; 김성배 ; et al 2020
-
46
Research Laboratory
급성골수성 백혈병에서 CD34와 P-당단백의 발현
이제환
;
김우건
;
김상위
;
et al
1995
-
47
dissertation
비소세포폐암에서 항 PD-1 항체와 병용하는 자가 NK세포 요법
김어진
2022
1